HIV infections Trials in Durban, South Africa
Conditions / HIV infections / Durban, South Africa
HIV infections has been the subject of sustained clinical investigation across multiple research sites.
73 total trials for this combination
Showing top 10 of 73 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01231516 | A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults | COMPLETED | PHASE3 |
| NCT02362503 | Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00540449 | TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. | COMPLETED | PHASE3 |
| NCT00062660 | Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection | APPROVED_FOR_MARKETING | — |
| NCT02951052 | Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05168813 | Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern | COMPLETED | — |
| NCT00050895 | Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients | COMPLETED | PHASE3 |
| NCT03299049 | Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02938520 | Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05168813 | Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern | COMPLETED | — |